• 1
    Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose- sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-1334.
  • 2
    Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004;53:S143-S151.
  • 3
    Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003;1609:127-143.
  • 4
    Germinario R, Sniderman AD, Manuel S, et al. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism 1993;42:574-580.
  • 5
    Yarsuel Z, Cianflone K, Sniderman AD, et al. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991;16:495-499.
  • 6
    Van Harmelen V, Reynisdottir S, Cianflone K, et al. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation stimulating protein and insulin. J Biol Chem 1999;274:18243-18251.
  • 7
    Faraj M, Sniderman AD, Cianflone K. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J Lipid Res 2004;4:657-666.
  • 8
    Paglialunage S, Julien P, Tahiri Y, et al. Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels. J Lipid Res 2009;50:1109-1119.
  • 9
    Sniderman AD, Maslowska M, Cianflone K. Of mice and men (and women) and the acylation-stimulating protein pathway. Curr Opin Lipidol 2000;11:291-296.
  • 10
    Faraj M, Jones P, Sniderman AD, et al. Enhanced dietary fat clearance in postobese women. J Lipid Res 2001;42:571-580.
  • 11
    Yang Y, Lu HL, Zhang J, et al. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes 2010;30:439-446.
  • 12
    Cianflone K, Zhang XJ, Genest J, et al. Plasma acylation stimulating protein in coronary artery disease. Arterioscler Tromb Vasc Biol 1997;17:1239-1244.
  • 13
    Wu Y, Zhang J, Wen Y, et al. Increased acylation stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril 2009;91:213-219.
  • 14
    Swarbrick MM, Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 2008;6:87-102.
  • 15
    Cui J, Panse S, Falkner B. The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol 2011;75:26-33.
  • 16
    Hui X, Lam KS, Vanhoutte PM, et al. Adiponectin and cardiovascular health: an update. Br J Pharmacol 2012;165:574-590.
  • 17
    Gavrila A, Peng CK, Chan JL, et al. Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab 2003;88:2838-2843.
  • 18
    Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Biol Med (Maywood) 2001;226:963-977.
  • 19
    Farooqi IS, O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009;89:980S-984S.
  • 20
    Mueller WM, Gregoire FM, Stanhope KL, et al. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 1998;139:551-558.
  • 21
    Wellhoener P, Fruehwald-Schultes B, Kern W, et al. Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab 2000;85:1267-1271.
  • 22
    Griffen SC, Oostema K, Stanhope KL, et al. Administration of Lispro insulin with meals improves glycemic control, increases circulating leptin, and suppresses ghrelin, compared with regular/NPH insulin in female patients with type 1 diabetes. J Clin Endocrinol Metab 2006;91:485-491.
  • 23
    Teff KL, Elliott SS, Tschöp M, et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 2004;89:2963-2972.
  • 24
    Teff KL, Grudziak J, Townsend RR, et al. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab 2009;94:1562-1569.
  • 25
    Saleh J, Summers LK, Cianflone K, et al. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 1998;39:884-891.
  • 26
    Maslowska M, Vu H, Phelis S, et al. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 1999;29:679-686.
  • 27
    Al-Daghri NM, Al-Attas OS, Al-Rubeaan K, et al. Adipocytokine profile of type 2 diabetics in metabolic syndrome as defined by various criteria. Diabetes Metab Res Rev 2008;24:52-58.
  • 28
    Maslowska M, Scantlebury T, Germinario R, et al. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. J Lipid Res 1997;38:1-11.
  • 29
    Van Oostrom AJ, van Dijk H, Verseyden C, et al. Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3. Am J Clin Nutr 2004;79:510-515.
  • 30
    Matthan NR, Cianflone K, Lichtenstein AH, et al. Hydrogenated fat consumption affects acylation-stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women. J Lipid Res 2001;42:1841-1848.
  • 31
    Cianflone K, Zakarian R, Couillard C, et al. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res 2004;45:124-131.
  • 32
    Clemente-Postigo M, Queipo-Ortuño MI, Fernandez-Garcia D, et al. Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One 2011;6:e24783.
  • 33
    Carvalho CR, Bueno AA, Mattos AM, et al. Fructose alters adiponectin, haptoglobin and angiotensinogen gene expression in 3T3-L1 adipocytes. Nutr Res 2010;30:644-649.
  • 34
    Zhu S, Sun F, Li W, et al. Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Mol Cell Biochem 2011;353:305-313.
  • 35
    Astrand O, Carlsson M, Nilsson I, et al. Fast food study group. Weight gain by hyperalimentation elevates C-reactive protein levels but does not affect circulating levels of adiponectin or resistin in healthy subjects. Eur J Endocrinol 2010;163:879-885.
  • 36
    Hivert MF, Sun Q, Shrader P, et al. Higher adiponectin levels predict greater weight gain in healthy women in the Nurses' Health Study. Obesity (Silver Spring) 2011;19:409-415.
  • 37
    Faraj M, Havel PJ, Phélis S, et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003;88:1594-1602.
  • 38
    Swarbrick MM, Stanhope KL, Austrheim-Smith IT, et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008;51:1901-1911.
  • 39
    Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998;47:913-917.
  • 40
    Stanhope KL, Griffen SC, Bremer AA, et al. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am J Clin Nutr 2011;94:112-119.